Dual lympho-myeloproliferative disorder in a patient with t(8;22) with BCR-FGFR1 gene fusion.

Abstract:

:The case of a patient presenting with a myeloproliferative disorder (MPD) characterized by a t(8;22) (p12;q11) translocation was investigated. The rearrangement resulted in the production of BCR-FGFR1 and FGFR1-BCR chimeric transcripts after in-frame fusions of BCR exon 4 with FGFR1 exon 9 and FGFR1 exon 8 with BCR exon 5, respectively. The four previously reported patients with such translocation presented with an atypical chronic myeloid leukemia (CML) without Philadelphia chromosome. In addition to a myeloproliferation, the patient had a B cell proliferation. The phenotypic characterization of the lymphoid cells in the bone marrow showed a continuum of maturation from blast B cells to polyclonal lymphocytes. In the blood, B cells showed a complete polyclonal maturation. The BCR-FGFR1 gene fusion was detected by dual-color fluorescence in situ hybridization in both CD19- and CD19+ populations. In contrast to the other FGFR1-MPDs that show myeloid and T cell proliferation, we propose that this t(8;22) MPD is a myeloid and B cell disease, and potentially a novel type of hematological disease. Although the FGFR1-MPD is rare, its study provides interesting clues to the understanding of hematopoietic stem cell biology and oncogene activation.

journal_name

Int J Oncol

authors

Murati A,Arnoulet C,Lafage-Pochitaloff M,Adélaide J,Derré M,Slama B,Delaval B,Popovici C,Vey N,Xerri L,Mozziconacci MJ,Boulat O,Sainty D,Birnbaum D,Chaffanet M

keywords:

subject

Has Abstract

pub_date

2005-06-01 00:00:00

pages

1485-92

issue

6

eissn

1019-6439

issn

1791-2423

journal_volume

26

pub_type

杂志文章
  • Increased interleukin-17A levels promote rituximab resistance by suppressing p53 expression and predict an unfavorable prognosis in patients with diffuse large B cell lymphoma.

    abstract::Rituximab resistance has become increasingly common in patients with diffuse large B cell lymphoma (DLBCL). However, the mechanisms involved remain unclear. In this study, we aimed to examine the effect of rituximab on interleukin (IL)-17A and to investigate the role of IL-17A in rituximab resistance and its prognosti...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2018.4299

    authors: Zhong W,Xu X,Zhu Z,Yang L,Du H,Xia Z,Yuan Z,Xiong H,Du Q,Wei Y,Li Q

    更新日期:2018-05-01 00:00:00

  • aP2-Cre-mediated expression activation of an oncogenic PLAG1 transgene results in cavernous angiomatosis in mice.

    abstract::The developmentally regulated PLAG1 proto-oncogene has been implicated in the development of various human tumor types, such as pleomorphic salivary gland adenomas, lipoblastomas, hepatoblastomas and AML. In previous studies, we generated two independent PLAG1 transgenic founder strains, PTMS1 and PTMS2, in which PLAG...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Van Dyck F,Scroyen I,Declercq J,Sciot R,Kahn B,Lijnen R,Van de Ven WJ

    更新日期:2008-01-01 00:00:00

  • Wild-type p53 in cellular-transformation - a reassessment.

    abstract::We found that a mouse p53 cDNA clone (pP53-5; Jenkins et al, Nature 312: 651-654, 1984), which previously was characterized as encoding mutant p53 protein, in fact represents wild-type mouse p53 cDNA, as we were able to demonstrate that the mutations described represented sequencing artefacts (compressions). Such sequ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.3.1.23

    authors: Kolzau T,Deppert W

    更新日期:1993-07-01 00:00:00

  • Iodine‑131 metabolic radiotherapy leads to cell death and genomic alterations through NIS overexpression on cholangiocarcinoma.

    abstract::Cholangiocarcinoma (CC) is an aggressive liver tumor with limited therapeutic options. Natrium‑iodide symporter (NIS) mediates the uptake of iodine by the thyroid, representing a key component in metabolic radiotherapy using iodine‑131 (131I) for the treatment of thyroid cancer. NIS expression is increased in CC, prov...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2020.4957

    authors: Brito AF,Abrantes AM,Teixo R,Pires AS,Ribeiro AC,Ferreira RF,Mascarenhas A,Puga T,Laranjo M,Caramelo F,Boin I,Jefferson DM,Gonçalves C,Martins R,Tavares I,Ribeiro IP,Sarmento-Ribeiro AB,Carreira IM,Souza D,Tralhão J

    更新日期:2020-03-01 00:00:00

  • PRL-3 improves colorectal cancer cell proliferation and invasion through IL-8 mediated glycolysis metabolism.

    abstract::Phosphatase of regenerating liver-3 (PRL-3) has been found to be overexpressed in liver metastases of colorectal cancer and rarely expressed in primary tumors, which plays an important role in the metastasis of colorectal cancer cells. Metabolism reprogramming has been found to be a hallmark of cancer cells, and aerob...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2017.4090

    authors: Xu H,Zeng Y,Liu L,Gao Q,Jin S,Lan Q,Lai W,Luo X,Wu H,Huang Y,Chu Z

    更新日期:2017-10-01 00:00:00

  • Ectopic expression of MyD118/Gadd45/CR6 (Gadd45beta/alpha/gamma) sensitizes neoplastic cells to genotoxic stress-induced apoptosis.

    abstract::The MyD118/Gadd45/CR6 gene family (also termed Gadd45beta/alpha/gamma) has been identified as genes which are rapidly induced by genotoxic agents, during terminal differentiation, as well as by apoptotic cytokines. In recent years, evidence has emerged that the proteins encoded by these genes play pivotal roles in neg...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Zhang W,Hoffman B,Liebermann DA

    更新日期:2001-04-01 00:00:00

  • Suppression of lysyl-tRNA synthetase, KRS, causes incomplete epithelial-mesenchymal transition and ineffective cell‑extracellular matrix adhesion for migration.

    abstract::The cell-adhesion properties of cancer cells can be targeted to block cancer metastasis. Although cytosolic lysyl-tRNA synthetase (KRS) functions in protein synthesis, KRS on the plasma membrane is involved in cancer metastasis. We hypothesized that KRS is involved in cell adhesion-related signal transduction for cell...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2016.3381

    authors: Nam SH,Kang M,Ryu J,Kim HJ,Kim D,Kim DG,Kwon NH,Kim S,Lee JW

    更新日期:2016-04-01 00:00:00

  • Analysis of cell kinetics after gamma-ray irradiation using an anti-BrdU monoclonal antibody.

    abstract::The cell cycle was analyzed using double staining with an anti-bromodeoxyuridine (BrdU) monoclonal antibody and propidium iodide (PI). Changes in cell kinetics after irradiation were compared with those seen by the conventional PI-based DNA histogram method. The effect of irradiation on cell kinetics has been studied ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.12.2.345

    authors: Murata T,Akagi K,Nasu R,Kimura H,Tanaka Y

    更新日期:1998-02-01 00:00:00

  • Expression of p53, PCNA, Ki-67 and bcl-2 in relation to risk factors in oral cancer - a molecular epidemiological study.

    abstract::A group of 133 primary oral squamous cell carcinomas were studied concerning a relationship between exposure factors and tumour biological parameters with a focus on the TP53 gene and p53 protein status. Tumours were evaluated using immunohistochemistry (IHC) for expression of p53, PCNA, Ki-67 and bcl-2 proteins. The ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.22.4.861

    authors: Schildt EB,Nylander K,Eriksson M,Hardell L,Magnusson A,Roos G

    更新日期:2003-04-01 00:00:00

  • Identification of circulating prostate cancer cells: a challenge to the clinical implementation of molecular biology (review).

    abstract::Conventional diagnosis of prostate cancer does not appear to be sensitive enough to differentiate pre-operatively between organ-confined and extracapsular disease. New technologies, arising from the field of molecular biology, have been introduced to improve diagnosis and their implementation into the clinical practic...

    journal_title:International journal of oncology

    pub_type: 杂志文章,评审

    doi:

    authors: Schamhart DH,Maiazza R,Kurth KH

    更新日期:2005-03-01 00:00:00

  • Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells.

    abstract::Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a major limitation for its clinical use. The mechanisms of TRAIL resistance have been mostly studied in the context of cell lines that are intrinsically resistant to TRAIL. However, little is known about the molecular alterations that con...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2012.1748

    authors: Ouyang W,Yang C,Zhang S,Liu Y,Yang B,Zhang J,Zhou F,Zhou Y,Xie C

    更新日期:2013-02-01 00:00:00

  • Enhancement of the effect of 5-aminolevulinic acid-based photodynamic therapy by simultaneous hyperthermia.

    abstract::In the present study, we have investigated a combination of photodynamic therapy (PDT) using 5-aminolevulinic acid (ALA) and simultaneous hyperthermia (HT) on osteosarcoma (HOSM-1) cells, squamous cell carcinoma (KB) cells and fibroblasts (HF), including an assessment of the differences in the sensitivity of these cel...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Yanase S,Nomura J,Matsumura Y,Nagai K,Kinoshita M,Nakanishi H,Ohnishi Y,Tokuda T,Tagawa T

    更新日期:2005-07-01 00:00:00

  • Metformin increases sensitivity of osteosarcoma stem cells to cisplatin by inhibiting expression of PKM2.

    abstract::Multiple drug resistance is reported to be a major obstacle in treatment of osteosarcoma (OS). Research has demonstrated that small subsets of cells called cancer stem cells (CSCs) are responsible for multiple drug resistance. CSCs are potential targets for reversing chemoresistance. In the present study, we compared ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2017.3950

    authors: Shang D,Wu J,Guo L,Xu Y,Liu L,Lu J

    更新日期:2017-05-01 00:00:00

  • Sensitivity of fresh isolates of soft tissue sarcoma, osteosarcoma and giant cell tumour cells to Apo2L/TRAIL and doxorubicin.

    abstract::Chemotherapy is an established treatment modality for bone sarcomas such as osteosarcoma (OS). However, the use of chemotherapy in high-grade soft tissue sarcomas remains controversial, with the most active chemotherapeutic agent, doxorubicin (DOX), reported to have a response rate of, at best only 34% and most studie...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.24.5.1263

    authors: Bouralexis S,Clayer M,Atkins GJ,Labrinidis A,Hay S,Graves S,Findlay DM,Evdokiou A

    更新日期:2004-05-01 00:00:00

  • How surgeon age affects post-treatment surveillance strategies for melanoma patients.

    abstract::The intensity of post-treatment melanoma patient follow-up varies widely among physicians. We investigated whether physician age accounts for the observed variation in surveillance intensity among plastic surgeons. A custom-designed questionnaire was mailed to USA and non-USA surgeons, all of whom were members of the ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.19.1.175

    authors: Margenthaler JA,Virgo KS,Johnson DY,Sugarbaker EM,Handler BS,Johnson FE

    更新日期:2001-07-01 00:00:00

  • MAP kinase pathways involved in glioblastoma response to erucylphosphocholine.

    abstract::Erucylphosphocholine (ErPC) is a promising antineoplastic drug for the treatment of malignant brain tumors. It exerts strong anticancer activity and induces apoptosis even in chemoresistant glioma cells. In the present study, A172 and U373MG glioma cells were treated with ErPC to explore the contribution of MAP kinase...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Kugler W,Erdlenbruch B,Otten K,Jendrossek V,Eibl H,Lakomek M

    更新日期:2004-12-01 00:00:00

  • Antisense- and siRNA-mediated inhibition of the anti-apoptotic gene Bcl-xL for chemosensitization of bladder cancer cells.

    abstract::Bcl-xL is an apoptosis inhibitor that is upregulated in bladder cancer (BCa) and provides an attractive target for molecular therapies. Treatment with specific antisense oligodeoxynucleotides (AS‑ODNs) or small interfering RNAs (siRNAs) were able to sensitize BCa cells to conventional chemotherapeutics. Ten new Bcl‑xL...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2015.3096

    authors: Rieger C,Huebner D,Temme A,Wirth MP,Fuessel S

    更新日期:2015-09-01 00:00:00

  • Recapitulation of a normal cellular growth program in early invasive breast-cancer.

    abstract::With a view to identifying markers reflecting not the evidence of, but the potential for, neoplastic progression of the breast we have compared the normal invasive mammary epithelial cell growth seen at puberty with invasive and non-invasive carcinogenesis using the mouse as a model. We have analyzed cell proliferatio...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Djonov V,Altermatt H,Arnold A,Gerber H,Andres A

    更新日期:1995-08-01 00:00:00

  • Deciphering the role of paclitaxel in the SKGT4 human esophageal adenocarcinoma cell line.

    abstract::Paclitaxel (taxol) has been used for the treatment of various human tumors and is an exceedingly efficient chemotherapy agent against esophageal cancer. However, the precise molecular mechanisms of paclitaxel effects on human esophageal adenocarcinoma cells are not well understood. MTT assay and cell cycle analysis we...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2011.1135

    authors: Kim SJ,Chung MJ,Kim JS,Kim B,Park WH,Kim SH,Kim SZ,Lee JS,Kim SM

    更新日期:2011-12-01 00:00:00

  • Prognostic value of estrogen receptor status can be improved by combined evaluation of p53, Bcl2 and PgR expression: an immunohistochemical study on breast carcinoma with long-term follow-up.

    abstract::Steroid receptor analysis is the only widely accepted prognostic/predictive marker in breast cancer (BC) treatment. In the present study we evaluated the prognostic role of ER/PgR with p53 and Bcl2, in a series of 277 BC (153 pN1/2, 122 pNO, 2 pNx) with a long-term follow-up (67 months for DFS, 75 months for OS). Our ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.15.6.1137

    authors: Mauri FA,Maisonneuve P,Caffo O,Veronese S,Aldovini D,Ferrero S,Cozzaglio F,Dalla Palma P,Galligioni E,Barbareschi M

    更新日期:1999-12-01 00:00:00

  • Delimiting the use of comparative genomic hybridization in human myeloid neoplastic disorders.

    abstract::Hematopoietic disorders can be used as a suitable tool of additional information on the actual resolving power of comparative genomic hybridization (CGH). Therefore, CGH examination was performed of DNA extracted from 23 acute and 15 chronic myeloproliferative disorders which had just been analyzed using classical cyt...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.16.6.1099

    authors: Gebhart E,Verdorfer I,Saul W,Trautmann U,Brecevic L

    更新日期:2000-06-01 00:00:00

  • Surgical procedures in gallbladder cancer with special reference to its macroscopic appearance.

    abstract::To investigate the relationships of the gross appearance to cancer depth and microinvasion in gallbladder cancer, thirty-three cancers were macroscopically subgrouped: papillary (n=8), nodular (n=6), papillo-invasive (n=1), nodulo-invasive (n=11), and invasive (n=7) type, respectively. Papillary type cancers were limi...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Namieno T,Takahashi M,Koito K,Sato N,Uchino J

    更新日期:1996-02-01 00:00:00

  • Patched 2, located in 1p32-34, is not mutated in high stage neuroblastoma tumors.

    abstract::Neuroblastoma is a childhood malignancy originating from cells of the sympathetic nervous system, exhibiting a marked diversity in outcome, with spontaneous regression at one end of the spectrum and severe disease and death at the other end. Features associated with frequent recurrence, a poor prognosis, and high tumo...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.16.5.943

    authors: Jögi A,Abel F,Sjöberg RM,Toftgård R,Zaphiropoulos PG,Påhlman S,Martinsson T,Axelson H

    更新日期:2000-05-01 00:00:00

  • Cytokine gene expression signature in ovarian clear cell carcinoma.

    abstract::Cytokine expression in a tumor microenvironment can impact both host defense against the tumor and tumor cell survival. In this study, we sought to clarify whether the cytokine gene expression profile could have clinical associations with ovarian cancer. We analyzed the expression of 16 cytokine genes (IL-1α, IL-1β, I...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2012.1533

    authors: Yanaihara N,Anglesio MS,Ochiai K,Hirata Y,Saito M,Nagata C,Iida Y,Takakura S,Yamada K,Tanaka T,Okamoto A

    更新日期:2012-09-01 00:00:00

  • The oncometabolite d‑2‑hydroxyglutarate induces angiogenic activity through the vascular endothelial growth factor receptor 2 signaling pathway.

    abstract::The mutation of isocitrate dehydrogenase (IDH)1 (R132H) and IDH2 (R172K) and the induction of hypoxia in various solid tumors results in alterations in metabolic profiles, including the production of the d‑ or l‑forms of 2‑hydroxyglutarate (2HG) from α‑ketoglutarate in aerobic metabolism in the tricarboxylic acid (TCA...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2018.4649

    authors: Seok J,Yoon SH,Lee SH,Jung JH,Lee YM

    更新日期:2019-02-01 00:00:00

  • Characterization of receptors for growth hormone-releasing hormone in human osteosarcomas and Ewing's sarcomas.

    abstract::Antagonists of growth hormone-releasing hormone (GH-RH) inhibit growth of various human cancers including osteosarcomas and Ewing's sarcomas, xenografted into nude mice or cultured in vitro. The antiproliferative effect of GH-RH antagonists could be mediated, in part, through the splice variants (SVs) of receptors for...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Halmos G,Schally AV,Bernardino AL,Varga JL

    更新日期:2006-08-01 00:00:00

  • Antitumor activity of ginsenoside Rg3 in melanoma through downregulation of the ERK and Akt pathways.

    abstract::Advanced metastatic melanoma is a malignant tumor for which there is currently no effective treatment due to resistance development. Ginsenoside Rg3, a saponin component extracted from ginseng roots, has been shown to reduce melanoma cell proliferation by decreasing histone deacetylase 3 and increasing p53 acetylation...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2019.4787

    authors: Meng L,Ji R,Dong X,Xu X,Xin Y,Jiang X

    更新日期:2019-06-01 00:00:00

  • Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion.

    abstract::Abnormal activation of signal transducer and activator of transcription 3 (STAT3) serves a pivotal role in oral squamous cell carcinoma (OSCC) tumor cell invasion into normal tissues or distant organs. However the downstream regulatory network of STAT3 signaling remains unclear. The present study aimed to investigate ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2018.4293

    authors: Wang Y,Guo W,Li Z,Wu Y,Jing C,Ren Y,Zhao M,Kong L,Zhang C,Dong J,Shuang Y,Sun S,Chen J,Wu C,Qiao Y,Qu X,Wang X,Zhang L,Jin R,Zhou X

    更新日期:2018-04-01 00:00:00

  • Multiple sites of loss of heterozygosity on chromosome 8 in human breast cancer has differential correlation with clinical parameters.

    abstract::Recent studies have shown that chromosome 8p21-22 is the main site of frequent loss of heterozygosity (LOH) in breast cancers. However, the detailed molecular analysis of chromosome 8 so far in breast cancer has been variable. Most of the literature pertaining to LOH in breast cancer is mainly on short arm of chromoso...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.12.4.811

    authors: Dahiya R,Perinchery G,Deng G,Lee C

    更新日期:1998-04-01 00:00:00

  • Aberrant expression of p53 and retinoblastoma gene products in human esophageal squamous cell carcinoma.

    abstract::The aberrant expression of p53 and RB proteins was investigated by immunohistochemistry in 73 patients with esophageal SCC, who underwent esophageal resection. Fresh tumor tissues from 21 patients were also tested for p53 mutations in exons 4 through 9 by direct sequencing. Positive nuclear staining with p53 antibody ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.11.5.1109

    authors: Ishikawa T,Furihata M,Ohtsuki Y,Ono H,Inoue A,Ogoshi S

    更新日期:1997-11-01 00:00:00